PD-L1 Targeting Molecular Imaging of Solid Tumors
Clinical trial NCT04629326 · RECRUITING
Trial details
- NCT number
- NCT04629326
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-20
- Primary completion
- 2024-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.